QUCYHealthcare · Diagnostics & Research

QUCY Stock Forecast: Quantum Cyber NV Price Predictions for 2026-2027

Last close, 21 Aug 2026

$1.30

The 2 Wall Street analysts covering Quantum Cyber NV hold a median 12-month price target of $9 — +592.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 6 of 100 as at 22 Aug 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap

$109.3M

Ticker Nerd rank

6 / 100

Median analyst target

$9.00

Analysts covering

Ticker Nerd rank

QUCY stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Quantum Cyber NV on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026

6 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Revisions

Momentum

Volatility

Issuance

Accruals

Growth

Quality

Value

Size (75): Smaller than most of the companies we track.

Value (1): The shares cost a lot relative to the profits and assets behind them.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

QUCY stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on QUCY, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says2 analysts

1 Buy1 Hold0 Sell

Low $9.00Median $9.00High $9.00

The green dot is the last close — the median target sits +592.3% from it.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. QUCY appears on the weeks it earns a place.

Estimates

QUCY analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

Quantum Cyber NV (QUCY) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.5×
Price / sales: 212.1×
Price / book: 3.7×
EV / EBITDA: −5.8×

Growth & margins

Revenue growth (YoY): −100.0%
Earnings growth (YoY): —
Gross margin: —
Operating margin: −3205.6%
Net margin: 72.6%

Returns & dividend

Return on equity: −212.5%
Return on assets: −64.9%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Quantum Cyber NV (QUCY) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Quantum Cyber NV has a market value of $109.3M and an enterprise value of $96.1M.
Shares outstanding: 12.5M.
Trailing P/E: −0.5×; forward P/E: −1.5× — the forward figure prices analyst consensus estimates, not reported earnings.
Quantum Cyber NV employs 10 people.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 24 Aug 2026

Data provided by Twelve Data

Peers

QUCY vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDiagnostics & Research

Company	Market cap	TKN rank
QUCYQuantum Cyber NV	$109.3M	6
IMDXInsight Molecular Diagnostics, Inc.	$139.6M	39
XGNExagen, Inc.	$190.5M	66
PRPOPrecipio, Inc.	$53.3M	52
BDSXBiodesix, Inc.	$275.8M	87
MYGNMyriad Genetics, Inc.	$299.2M	52
FLGTFulgent Genetics, Inc.	$565.2M	46

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Quantum Cyber NV — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest QUCY news & analysis

Quantum Cyber Rejects Threat of Future Publications from Short-Seller Adam Gefvert Demanding Withdrawal of $5.69 Million Lawsuit

GlobeNewsWire · 20 Aug 2026negative

Quantum Cyber disclosed that it rejected threats of future publications from short-seller Adam Gefvert, who demanded withdrawal of its $5.69 million lawsuit, and revealed a written email offer from Gefvert to suspend future short-seller reports if the case were dropped. The company warned that false short-seller narratives impact American job creation and hurt the working families behind its Bridgeport, Connecticut manufacturing plant, and noted parallels to federal short-seller enforcement actions including July 2024 SEC and DOJ charges against Andrew Left of Citron Research.

Why it matters — A QUCY watcher would care because the company is publicly defending its litigation and reputation against an active short-seller campaign while linking the dispute to federal enforcement actions.

Quantum Cyber to Participate in Invitation-Only 1640 Society Hamptons Family Office Wealth Forum 2026

GlobeNewsWire · 17 Aug 2026positive

Quantum Cyber will take part in the invitation-only 1640 Society Hamptons Family Office Wealth Forum 2026, where its President of Quantum Drones Corporation and CEO of Strategic Quantum Antenna will speak on a "The Future of Defense Tech" panel before a closed audience of ultra-high-net-worth family offices, homeland security investors, and former federal executives.

Why it matters — A QUCY watcher would care because the company's executives are gaining exposure to a private, high-net-worth and government-connected audience relevant to its defense-technology business.

Quantum Cyber Unveils the Quantum Photonic Antenna and Publishes Inaugural Technical White Paper Detailing the Quantum Layer of Its Autonomous Defense Platform

GlobeNewsWire · 13 Aug 2026positive

Quantum Cyber unveiled its Quantum Photonic Antenna and published its inaugural technical white paper detailing the quantum layer of its autonomous defense platform. The photonic architecture extends from autonomous drones to low-latency satellite-to-ground and space-based optical communications, and is aligned with the company's board-approved initiative to acquire an equity stake in SpaceX, as well as relevant White House executive orders and the national quantum initiative framework.

Why it matters — For QUCY watchers, this marks a technical milestone that positions the company's quantum photonic technology within the broader autonomous defense and satellite communications landscape and ties into its planned strategic partnership with SpaceX.

StreetWatch: As Federal Funding Floods the Drone Market, Quantum Cyber Is Assembling a Next Generation Platform

Newsfile Corp · 3 Aug 2026positive

Washington is accelerating its drone strategy on two fronts: directing significant capital into domestic production and targeting supply chains behind Iranian UAVs. Quantum Cyber N.V. is reported to be assembling a next-generation platform amid this shift.

Why it matters — A QUCY watcher would care because federal drone-sector funding and supply-chain policy could create a larger market context for Quantum Cyber's next-generation platform development.

Quantum Cyber Applauds President Trump's Drone Dominance Program and Supply Chain Framework, Reaffirms Commitment to On-Shore U.S. Manufacturing of Autonomous Systems

GlobeNewsWire · 29 July 2026positive

Quantum Cyber NV issued a statement congratulating President Trump and applauding his Drone Dominance Program and Supply Chain Framework, while reaffirming the company's commitment to on-shore U.S. manufacturing of autonomous systems.

Why it matters — The statement signals QUCY's alignment with federal policy priorities that could directly affect its business in drone warfare, counter-UAS, and border security markets.

FAQ

Frequently asked questions about QUCY stock

What is the QUCY stock price forecast for 2026-2027?

The 2 Wall Street analysts covering Quantum Cyber NV have a median 12-month price target of $9, with estimates ranging from $9 to $9. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is QUCY stock a buy right now?

Of the 2 analysts covering Quantum Cyber NV, 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Quantum Cyber NV 6 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank QUCY?

As at 22 Aug 2026, Quantum Cyber NV ranks 6 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (75 of 100).

Will QUCY stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +592.3% from the last close, and Ticker Nerd's factor model ranks Quantum Cyber NV 6 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the QUCY stock forecast for 2030?

No analyst covering Quantum Cyber NV publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for QUCY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $9 to $9 over the next 12 months.

What does Quantum Cyber NV do?

What is the latest news on QUCY?

The most recent item we track (GlobeNewsWire, 20 Aug 2026): "Quantum Cyber Rejects Threat of Future Publications from Short-Seller Adam Gefvert Demanding Withdrawal of $5.69 Million Lawsuit". Quantum Cyber disclosed that it rejected threats of future publications from short-seller Adam Gefvert, who demanded withdrawal of its $5.69 million lawsuit, and revealed a written email offer from Gefvert to suspend future short-seller reports if the case were dropped. The company warned that false short-seller narratives impact American job creation and hurt the working families behind its Bridgeport, Connecticut manufacturing plant, and noted parallels to federal short-seller enforcement actions including July 2024 SEC and DOJ charges against Andrew Left of Citron Research.

Company

About Quantum Cyber NV.

Mainz Biomed N.V. is a molecular genetics diagnostic company specializing in the development of market-ready solutions for the early detection of life-threatening conditions, particularly colorectal and pancreatic cancers. Its flagship product, ColoAlert, is a non-invasive genetic test that outperforms the standard fecal immunochemical test (FIT) in detecting colorectal tumors by analyzing specific genetic markers in stool samples, enabling earlier intervention and better patient outcomes. The company is also advancing proprietary genetic testing methods for pancreatic cancer screening, addressing one of the most challenging areas in oncology diagnostics. Mainz Biomed N.V. focuses on creating simple, affordable, and reliable tools that empower healthcare providers and patients with accessible early detection options, manufactured to high standards including DIN EN ISO 13485 certification. Operating from Mainz, Germany, in a hub for advanced DNA and pharmaceutical research, the company contributes to the biotechnology sector by prioritizing innovative, cost-effective diagnostics that support preventive healthcare strategies worldwide. Founded in 2008, Mainz Biomed N.V. remains dedicated to genetic and genomic testing tailored to individual disease profiles.

CEO Mr. David Elliot Lazar · 10 employees · Germany · https://quantum-cyber.ai